ArticleScientific reports2019
Chemical proteomics reveals target selectivity of clinical Jak inhibitors in human primary cells.
H Christian Eberl et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papercites it